Global Evidence Review on Health and Migration: Capturing the evidence on access to essential antibiotics in migrant and refugee populations – World Health Organization

Share Article

Antimicrobial Resistance (AMR) is a complex global health challenge, with significant implications for human health, social well-being, and economic development.  
On 6 September 2022, WHO will hold a high-level webinar to share the findings of the Global Evidence Review on Health and Migration (GEHM) with a focus on AMR. The report, the fourth of the GEHM series, explores evidence on access and use of essential antimicrobials in international migrant and refugee populations and provides policy considerations to support policymakers in addressing national and global challenges related to AMR and migration.  
Launched on 17 June 2021, the GEHM series is an evidence-informed normative product to respond to policy questions on migration-related public health priorities. The GEHM series also addresses knowledge gaps and proposes policy considerations on the health status and health policies related to refugees and migrants by summarizing the best available evidence worldwide.  
The upcoming GEHM on AMR is the result of the interdivisional collaboration between WHO’s Health and Migration Programme (PHM), the Department of Surveillance, Prevention and Control (SPC) of the Antimicrobial Resistance Division (AMR), and the Global Strategy Lab at York University – the WHO Collaborating Centre on Global Governance of Antimicrobial resistance. PHM and SPC/AMR departments partnered with WHO Regional Offices, the International Organization for Migration (IOM), the Office of the United Nations High Commissioner for Refugees (UNHCR), Médecins Sans Frontières (MSF), and ReAct to identify supplementary evidence, with an emphasis on identifying case studies and best practices for policy considerations and interventions. 
The event is open to everyone but is particularly aimed at high level policymakers, including ministries of health, health sector managers, academic institutions, and other key stakeholders. 
The event will take place on Tuesday 6 September 2022 from 14:00 to 15:00 CEST (timezone adjuster). 
Chair – Dr Santino Severoni, Director, Health and Migration Programme (PHM), WHO
Chair – Rifat Hossain, Data and evidence, PHM, WHO
Strategic importance of Global Evidence review on Health and Migration (GEHM) for policy making for refugees and migrants 
Ensuring the integration of refugees and migrants into immunization policies, planning and service delivery globally 
Continuum of care for noncommunicable disease management during the migration cycle
Refugees and migrants in times of COVID-19: mapping trends of public health and migration policies and practices
Fact sheets

Health and Migration Programme
Refugee and Migrant Health
Department of Surveillance, Prevention and Control (SPC) of the Antimicrobial Resistance Division (AMR)

Setting evidence-informed norms and standards on refugee and migrant health


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort